Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Needham & Company LLC restated their buy rating on shares of Lucid Diagnostics (NASDAQ:LUCD – Free Report) in a research report report published on Monday, Benzinga reports. Needham & Company LLC currently has a $2.50 price objective on the stock. Separately, Cantor Fitzgerald lowered their target price on shares of Lucid Diagnostics from $3.80 to […]
Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Monday, May 13th. Individual interested in registering for the company’s earnings conference call can do so using this link. Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) last released its quarterly earnings data on Tuesday, March […]
Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, May 8th. Analysts expect Accelerate Diagnostics to post earnings of ($0.72) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Accelerate Diagnostics (NASDAQ:AXDX […]
Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) is scheduled to announce its earnings results before the market opens on Monday, May 13th. Parties that are interested in registering for the company’s conference call can do so using this link. Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) last posted its quarterly earnings data on Tuesday, March […]
/PRNewswire/ -- Last month a new utility patent, US Patent 11,953,501, was issued to LSU Health New Orleans for a noninvasive test called NECDetect that aids...